These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6304217

  • 1. Preponderance of alpha 2- over beta 1-adrenergic receptor sites in human fat cells is not predictive of the lipolytic effect of physiological catecholamines.
    Lafontan M, Berlan M, Villeneuve A.
    J Lipid Res; 1983 Apr; 24(4):429-40. PubMed ID: 6304217
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of the beta-adrenergic receptors of hamster white fat cells. Evidence against an important role for the alpha 2-receptor subtype in the adrenergic control of lipolysis.
    Pecquery R, Leneveu MC, Giudicelli Y.
    Biochim Biophys Acta; 1983 Jun 23; 731(3):397-405. PubMed ID: 6305418
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences.
    Mauriege P, Galitzky J, Berlan M, Lafontan M.
    Eur J Clin Invest; 1987 Apr 23; 17(2):156-65. PubMed ID: 3034620
    [Abstract] [Full Text] [Related]

  • 5. Fat cell adrenoceptors: inter- and intraspecific differences and hormone regulation.
    Lafontan M, Berlan M, Carpene C.
    Int J Obes; 1985 Apr 23; 9 Suppl 1():117-27. PubMed ID: 2999011
    [Abstract] [Full Text] [Related]

  • 6. Age-related changes in adrenergic alpha 1, alpha 2, and beta receptors of rat white fat cell membranes: an analysis using [3H]bunazosin as a novel ligand for the alpha 1 adrenoceptor.
    Kobatake T, Watanabe Y, Matsuzawa Y, Tokunaga K, Fujioka S, Kawamoto T, Keno Y, Tarui S, Yoshida H.
    J Lipid Res; 1991 Feb 23; 32(2):191-6. PubMed ID: 1676718
    [Abstract] [Full Text] [Related]

  • 7. Alpha 2-adrenergic binding and action in human adipocytes. Comparison between binding to plasma membrane preparations and to intact adipocytes.
    Richelsen B, Pedersen O.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):101-12. PubMed ID: 2867917
    [Abstract] [Full Text] [Related]

  • 8. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A, Convents D, De Backer JP, De Keyser J, Vauquelin G.
    Biochem Pharmacol; 1989 Feb 01; 38(3):455-63. PubMed ID: 2563652
    [Abstract] [Full Text] [Related]

  • 9. The (--)[3H]dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of beta-adrenergic sites.
    Dax EM, Partilla JS, Gregerman RI.
    J Lipid Res; 1982 Sep 01; 23(7):1001-8. PubMed ID: 6292316
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of beta-adrenergic-agonist binding to rat adipocyte membranes. Evidence that (+/-)-[3H]hydroxybenzylisoproterenol interacts selectively with the adipocyte beta-adrenergic receptors.
    Giudicelli Y, Lacasa D, Agli B.
    Biochim Biophys Acta; 1982 Mar 15; 715(1):105-15. PubMed ID: 6122470
    [Abstract] [Full Text] [Related]

  • 11. [3H]rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha 2-adrenergic receptors.
    Perry BD, U'Prichard DC.
    Eur J Pharmacol; 1981 Dec 17; 76(4):461-4. PubMed ID: 6276200
    [Abstract] [Full Text] [Related]

  • 12. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
    Berlan M, Lafontan M, Dang Tran L.
    J Physiol (Paris); 1980 Dec 17; 76(2):133-46. PubMed ID: 6249915
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM, Hess HJ, Grodski A, Graham RM, Homcy CJ.
    Mol Pharmacol; 1986 Mar 17; 29(3):219-27. PubMed ID: 3005829
    [Abstract] [Full Text] [Related]

  • 14. Restricted alpha- and beta-adrenoceptor affinity of sulfoconjugated catecholamines in human mononuclear leukocytes, platelets, and fat cells and reduction of the postreceptor mechanisms.
    Werle E, Michel G, Lenz T, Kather H, Schneider B, Weicker H.
    Int J Sports Med; 1988 Aug 17; 9 Suppl 2():S93-102. PubMed ID: 2846457
    [Abstract] [Full Text] [Related]

  • 15. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM, MacKinnon AC, McGrath JC, Spedding M, Kilpatrick AT.
    Br J Pharmacol; 1990 Apr 17; 99(4):803-9. PubMed ID: 1972896
    [Abstract] [Full Text] [Related]

  • 16. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
    Howe JR, Yaksh TL.
    Brain Res; 1986 Mar 12; 368(1):87-100. PubMed ID: 2869820
    [Abstract] [Full Text] [Related]

  • 17. A reliable assay for beta-adrenoceptors in intact isolated human fat cells with a hydrophilic radioligand, [3H]CGP-12177.
    Lacasa D, Mauriège P, Lafontan M, Berlan M, Giudicelli Y.
    J Lipid Res; 1986 Apr 12; 27(4):368-76. PubMed ID: 2873196
    [Abstract] [Full Text] [Related]

  • 18. Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.
    Mauriège P, De Pergola G, Berlan M, Lafontan M.
    J Lipid Res; 1988 May 12; 29(5):587-601. PubMed ID: 2900871
    [Abstract] [Full Text] [Related]

  • 19. Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
    Langin D, Portillo M, Dauzats M, Lafontan M.
    Endocrinology; 1992 Jan 12; 130(1):307-15. PubMed ID: 1309335
    [Abstract] [Full Text] [Related]

  • 20. Characterization of alpha 2-adrenergic receptors of calf retina membranes by [3H]-rauwolscine and [3H]-RX 781094 binding.
    Convents A, De Backer JP, Vauquelin G.
    Biochem Pharmacol; 1987 Aug 01; 36(15):2497-503. PubMed ID: 3038126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.